Menopause Hormone Therapy (HRT) in Rutland, VT

Bioidentical hormones in Rutland: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

For women in Rutland, a physician licensed in Vermont can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 9 OB-GYNs practicing in Rutland, about 57.2 for every 100,000 residents against 17.8 nationally and above Vermont's 21.2, a higher rate than 89% of the cities VevaMD covers. With about 2,237 women aged 45 to 64 living in Rutland, that is about 250 for each OB-GYN in the city, before counting any younger patients.

Beyond the city line the count barely changes: 10 OB-GYNs within 10 miles and 10 within 25, for the 101,163 people who live in that radius (9.9 per 100,000). None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Vermont reviewing your answers from home in Rutland.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11